Literature DB >> 2751229

Difethialone (LM-2219): a new anticoagulant rodenticide for use against warfarin-resistant and -susceptible strains of Rattus norvegicus and Mus musculus.

K Nahas1, G Lorgue, M Mazallon.   

Abstract

Data on the efficacy of difethialone, a new anticoagulant rodenticide derived from 4-hydroxybenzothiopyranone against rats and mice, are reported. After one day of feeding with 25 mg/kg of bait, 100 and 85%, respectively, male and female warfarin-susceptible Rattus norvegicus were killed. With the resistant strain, mortality was 90 and 94% for males and females, respectively. 100 and 96% of warfarin-sensitive males and females, respectively, were killed after 3 days of feeding with the same bait. Those of the resistant strain were respectively, 100 and 93%. In Mus musculus, after one day of feeding, mortality was 97, 94, 95 and 93% for males and females of susceptible and resistant strains, respectively, and 100, 97, 100 and 91% after 3 days of feeding. No significant difference in bait intake was observed between 25 mg/kg difethialone bait and a control bait. Compared to other anticoagulant rodenticides, these results show that difethialone is a promising rodenticide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751229

Source DB:  PubMed          Journal:  Ann Rech Vet        ISSN: 0003-4193


  2 in total

1.  Chiral liquid chromatography-tandem mass spectrometry analysis of superwarfarin rodenticide stereoisomers - Bromadiolone, difenacoum and brodifacoum - In human plasma.

Authors:  Daniel G Nosal; Douglas L Feinstein; Richard B van Breemen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2021-01-07       Impact factor: 3.318

2.  Separation and Quantification of Superwarfarin Rodenticide Diastereomers-Bromadiolone, Difenacoum, Flocoumafen, Brodifacoum, and Difethialone-in Human Plasma.

Authors:  Daniel G Nosal; Douglas L Feinstein; Luying Chen; Richard B van Breemen
Journal:  J AOAC Int       Date:  2020-06-01       Impact factor: 2.028

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.